Most Recent
Virbac loses bid to block generic animal drug
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories. 
Law firm can’t dodge $5.4M security in Macquarie class action
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
‘Truly lamentable’: Solicitors score partial win in tax appeal
Two Queensland solicitors have scored partial wins in their decades-long disputes with the tax office because of the Administrative Appeals Tribunal’s “wholesale failure” to give proper reasons.
ASIC can bring case against Rex Airlines, directors
ASIC has won approval to bring claims against troubled regional airline Rex and four of its directors for allegedly misleading investors about the company's financial position.
Top 10 class action settlements of 2024
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
High Court asked to weigh in on Katy Perry trade mark stoush
An Australian fashion designer has asked the High Court to overturn a Full Court win for singer Katy Perry in a long-running trade mark dispute, saying the court's findings “wrongly privilege the powerful and famous over ordinary traders”.
Toyota unit Hino to pay $87M to settle emissions cheating class action
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Dominique Grubisa, Master Wealth lose challenge to $6M penalty
The Full Court has rejected wealth guru Dominique Grubisa's argument that a judge who slapped her and her company with a $6 million penalty wrongly confused the ordinary consumer with “the most ignorant”.
‘Considerable disquiet’: Pelvic mesh group members can challenge $405M settlements
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
Judge rejects sacked Super Retail Group execs’ settlement claims
Two Super Retail Group executives' claims that they were unfairly sacked for making whistleblower complaints will go to trial after they lost their bid to enforce an alleged settlement.